Aptevo Therapeutics (APVO) EBIT (QoQ) (2015 - 2026)
Aptevo Therapeutics (APVO) EBIT (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Aptevo Therapeutics | 3.19 Mn | -6.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.76% |
| Mar 31, 2026 | -14.03% |
| Dec 31, 2025 | 21.21% |
| Sep 30, 2025 | -22.23% |
| Jun 30, 2025 | 3.92% |
| Mar 31, 2025 | -1.54% |
| Dec 31, 2024 | -22.42% |
| Sep 30, 2024 | 13.46% |
| Jun 30, 2024 | 13.73% |
| Mar 31, 2024 | -9.38% |
| Dec 31, 2023 | 2.70% |
| Sep 30, 2023 | 19.77% |
| Jun 30, 2023 | -5.44% |
| Mar 31, 2023 | -0.94% |
| Dec 31, 2022 | 1.28% |
| Sep 30, 2022 | -2.94% |
| Jun 30, 2022 | -34.77% |
| Mar 31, 2022 | -38.89% |
| Dec 31, 2021 | 14.95% |
| Sep 30, 2021 | 16.99% |